Clinical Features of Atlantoaxial Involvement in Patients with Rheumatoid Arthritis Using F-fluorodeoxyglucose-positron Emission Tomography with Computed Tomography

Overview

Journal Clin Rheumatol

Publisher Springer

Specialty Rheumatology

Date 2023 Mar 31

PMID 37000282

Authors

Atsushi Noguchi

Takashi Kurita

Katsura Matsuzawa

Affiliations

Soon will be listed here.

Abstract

Introduction/objectives: Cervical spine involvement is one of the most serious complications in rheumatoid arthritis (RA). The study aim was to assess the clinical significance of atlantoaxial (AA) joint involvement detected by F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) with computed tomography (CT) in patients with RA.

Method: A prospective cross-sectional study was conducted to evaluate AA joint involvement detected by FDG-PET/CT in consecutive RA patients from December 2017 to February 2022. We investigated the relationship between AA joint involvement and clinical data, including disease activity and patients' cervical symptoms.

Results: Among 48 patients enrolled, abnormal FDG uptake at AA joint was detected in 13 (27%). Rheumatoid factor titre, initial disease activity score 28-erythrocyte sedimentation rate and total standardized uptake value were significantly higher in the 13 patients than in the others (P = 0.004, P < 0.001 and P = 0.001, respectively). All patients with abnormal FDG uptake at AA joint had some cervical symptoms regardless of cervical spine X-ray abnormalities. Neck pain on movement and at rest were more frequent in the 13 patients than in the others (P = 0.001 and P = 0.004, respectively). The most sensitive symptom associated with AA joint involvement was neck pain on movement (sensitivity, 69%), and the most specific symptom was neck pain at rest (specificity, 100%).

Conclusions: AA joint involvement was commonly observed by FDG-PET/CT in patients with active RA, independent of radiographic findings. Specific cervical symptoms can be important surrogate markers for detection of potential AA synovitis associated with active RA. Key Points • AA joint involvement was frequently seen in RA with high disease activity independent of radiographic findings. • Neck pain was a hallmark of AA joint involvement reflecting disease activity, and resting pain was highly specific.

References

McInnes I, Schett G . Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017; 389(10086):2328-2337. DOI: 10.1016/S0140-6736(17)31472-1. View

Gillick J, Wainwright J, Das K . Rheumatoid Arthritis and the Cervical Spine: A Review on the Role of Surgery. Int J Rheumatol. 2015; 2015:252456. PMC: 4553335. DOI: 10.1155/2015/252456. View

Kotecki M, Sotniczuk M, Gietka P, Gasik R, Sudol-Szopinska I . Imaging of cervical spine involvement in inflammatory arthropathies: a review. Pol J Radiol. 2021; 86:e620-e629. PMC: 8652349. DOI: 10.5114/pjr.2021.111363. View

Wasserman B, Moskovich R, Razi A . Rheumatoid arthritis of the cervical spine--clinical considerations. Bull NYU Hosp Jt Dis. 2011; 69(2):136-48. View

Neva M, Hakkinen A, Makinen H, Hannonen P, Kauppi M, Sokka T . High prevalence of asymptomatic cervical spine subluxation in patients with rheumatoid arthritis waiting for orthopaedic surgery. Ann Rheum Dis. 2005; 65(7):884-8. PMC: 1798218. DOI: 10.1136/ard.2005.042135. View

Shlobin N, Dahdaleh N . Cervical spine manifestations of rheumatoid arthritis: a review. Neurosurg Rev. 2020; 44(4):1957-1965. DOI: 10.1007/s10143-020-01412-1. View

Zhang T, Pope J . Cervical spine involvement in rheumatoid arthritis over time: results from a meta-analysis. Arthritis Res Ther. 2015; 17:148. PMC: 4449959. DOI: 10.1186/s13075-015-0643-0. View

Manczak M, Gasik R . Cervical spine instability in the course of rheumatoid arthritis - imaging methods. Reumatologia. 2017; 55(4):201-207. PMC: 5647537. DOI: 10.5114/reum.2017.69782. View

Baker J, Conaghan P, Gandjbakhch F . Update on magnetic resonance imaging and ultrasound in rheumatoid arthritis. Clin Exp Rheumatol. 2018; 36 Suppl 114(5):16-23. View

10.

Kono M, Kamishima T, Yasuda S, Sakamoto K, Abe S, Noguchi A . Effectiveness of whole-body magnetic resonance imaging for the efficacy of biologic anti-rheumatic drugs in patients with rheumatoid arthritis: A retrospective pilot study. Mod Rheumatol. 2017; 27(6):953-960. DOI: 10.1080/14397595.2016.1276425. View

11.

Magarelli N, Simone F, Amelia R, Leone A, Bosello S, DAntona G . MR imaging of atlantoaxial joint in early rheumatoid arthritis. Radiol Med. 2010; 115(7):1111-20. DOI: 10.1007/s11547-010-0574-4. View

12.

Beckers C, Ribbens C, Andre B, Marcelis S, Kaye O, Mathy L . Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med. 2004; 45(6):956-64. View

13.

Fosse P, Kaiser M, Namur G, de Seny D, Malaise M, Hustinx R . F- FDG PET/CT joint assessment of early therapeutic response in rheumatoid arthritis patients treated with rituximab. Eur J Hybrid Imaging. 2018; 2(1):6. PMC: 5954768. DOI: 10.1186/s41824-017-0022-y. View

14.

Elzinga E, van der Laken C, Comans E, Boellaard R, Hoekstra O, Dijkmans B . 18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study. J Nucl Med. 2010; 52(1):77-80. DOI: 10.2967/jnumed.110.076711. View

15.

Kubota K, Ito K, Morooka M, Mitsumoto T, Kurihara K, Yamashita H . Whole-body FDG-PET/CT on rheumatoid arthritis of large joints. Ann Nucl Med. 2009; 23(9):783-91. DOI: 10.1007/s12149-009-0305-x. View

16.

Okamura K, Yonemoto Y, Okura C, Higuchi T, Tsushima Y, Takagishi K . Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT. BMC Musculoskelet Disord. 2014; 15:393. PMC: 4247755. DOI: 10.1186/1471-2474-15-393. View

17.

Suto T, Yonemoto Y, Okamura K, Okura C, Kaneko T, Kobayashi T . Predictive factors associated with the progression of large-joint destruction in patients with rheumatoid arthritis after biologic therapy: A post-hoc analysis using FDG-PET/CT and the ARASHI (assessment of rheumatoid arthritis by scoring of.... Mod Rheumatol. 2016; 27(5):820-827. DOI: 10.1080/14397595.2016.1266132. View

18.

Yonemoto Y, Okamura K, Takeuchi K, Kaneko T, Kobayashi T, Okura C . [18F]fluorodeoxyglucose uptake as a predictor of large joint destruction in patients with rheumatoid arthritis. Rheumatol Int. 2015; 36(1):109-15. DOI: 10.1007/s00296-015-3331-0. View

19.

Suto T, Okamura K, Yonemoto Y, Okura C, Tsushima Y, Takagishi K . Prediction of Large Joint Destruction in Patients With Rheumatoid Arthritis Using 18F-FDG PET/CT and Disease Activity Score. Medicine (Baltimore). 2016; 95(7):e2841. PMC: 4998646. DOI: 10.1097/MD.0000000000002841. View

20.

Yonemoto Y, Okamura K, Kobayashi T, Kaneko T, Okura C, Suto T . Predictive factors related to shoulder joint destruction in rheumatoid arthritis patients treated with biologics: A prospective study. Mod Rheumatol. 2016; 27(4):587-592. DOI: 10.1080/14397595.2016.1245125. View